Reason for request
Extension of indication
Clinical Benefit
| Substantial |
Substantial in type 1 diabetes in children aged 2 to 5 years. |
Clinical Added Value
| no clinical added value |
LANTUS provides no improvement in actual benefit (IAB V, non-existent) in the management of children aged 2 to 5 years with type 1 diabetes. |
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
xUrkCXjVhtCE9Yke
